Literature DB >> 16082368

Gene targeting using zinc finger nucleases.

Matthew H Porteus1, Dana Carroll.   

Abstract

The ability to achieve site-specific manipulation of the mammalian genome has widespread implications for basic and applied research. Gene targeting is a process in which a DNA molecule introduced into a cell replaces the corresponding chromosomal segment by homologous recombination, and thus presents a precise way to manipulate the genome. In the past, the application of gene targeting to mammalian cells has been limited by its low efficiency. Zinc finger nucleases (ZFNs) show promise in improving the efficiency of gene targeting by introducing DNA double-strand breaks in target genes, which then stimulate the cell's endogenous homologous recombination machinery. Recent results have shown that ZFNs can be used to create targeting frequencies of up to 20% in a human disease-causing gene. Future work will be needed to translate these in vitro findings to in vivo applications and to determine whether zinc finger nucleases create undesired genomic instability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082368     DOI: 10.1038/nbt1125

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  218 in total

1.  Modeling disease mutations by gene targeting in one-cell mouse embryos.

Authors:  Melanie Meyer; Oskar Ortiz; Martin Hrabé de Angelis; Wolfgang Wurst; Ralf Kühn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-01       Impact factor: 11.205

Review 2.  Safe harbours for the integration of new DNA in the human genome.

Authors:  Michel Sadelain; Eirini P Papapetrou; Frederic D Bushman
Journal:  Nat Rev Cancer       Date:  2011-12-01       Impact factor: 60.716

Review 3.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

4.  Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.

Authors:  Emi Aizawa; Yuka Hirabayashi; Yuzuru Iwanaga; Keiichiro Suzuki; Kenji Sakurai; Miho Shimoji; Kazuhiro Aiba; Tamaki Wada; Norie Tooi; Eihachiro Kawase; Hirofumi Suemori; Norio Nakatsuji; Kohnosuke Mitani
Journal:  Mol Ther       Date:  2011-12-06       Impact factor: 11.454

Review 5.  Group II introns: mobile ribozymes that invade DNA.

Authors:  Alan M Lambowitz; Steven Zimmerly
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

Review 6.  Salient Features of Endonuclease Platforms for Therapeutic Genome Editing.

Authors:  Michael T Certo; Richard A Morgan
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

Review 7.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

Review 8.  Custom-designed zinc finger nucleases: what is next?

Authors:  J Wu; K Kandavelou; S Chandrasegaran
Journal:  Cell Mol Life Sci       Date:  2007-11       Impact factor: 9.261

9.  TALEN-mediated gene targeting in porcine spermatogonia.

Authors:  Lin Tang; Alla Bondareva; Raquel González; Jose R Rodriguez-Sosa; Daniel F Carlson; Dennis Webster; Scott Fahrenkrug; Ina Dobrinski
Journal:  Mol Reprod Dev       Date:  2018-02-22       Impact factor: 2.609

10.  Targeted genome editing in Aedes aegypti using TALENs.

Authors:  Azadeh Aryan; Kevin M Myles; Zach N Adelman
Journal:  Methods       Date:  2014-02-18       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.